|
(P1741) |
Induced pluripotent stem cell derived endothelial cells as a promising endothelial cell source for tissue engineered vascularized constructs |
| |
|
D. Manikowski, B. Andrée, T. Horvath, L. Venturini, A. Haverich, A. Hilfiker (Hannover) |
|
(P1742) |
The release of miR‐29b into the coronary circulation correlates with positive coronary arterial remodeling
and decreased plaque fibrosis in patients with stable CAD. |
| |
|
R. De Rosa, J.-N. Boeckel, D. Leistner, S. M. Reis, C. E. Thome, S. Fichtlscherer, S. Fichtlscherer, S. Dimmeler, A. M. Zeiher (Frankfurt am Main, Berlin) |
|
(P1743) |
Platelet-derived growth factor-BB selectively augments non-canonical sonic hedgehog signalling in adventitial fibroblasts |
| |
|
J. M. Daniel, J. Dutzmann, A. Koch, J. Bauersachs, D. G. Sedding (Hannover) |
|
(P1744) |
Lung tissue remodelling in induced pulmonary hypertension: changes in extracellular matrix and fibrosis associated gene expression and identification of a novel target for antibody-based therapies |
| |
|
M. Franz, K. Grün, S. Betge, B. Ndongson-Dongmo, R. Bauer, C. Schulze, H.-R. Figulla, A. Berndt, C. Jung (Jena, Düsseldorf) |
|
(P1745) |
Pentaerythrityl tetranitrate (PETN) in vivo treatment lowers pulmonary artery pressure, oxidative stress and improves vascular function in monocrotaline-induced pulmonary hypertension |
| |
|
S. Steven, E. Ullmann, M. Oelze, M. Brandt, S. Kröller-Schön, T. Heeren, S. Daub, M. Dib, D. Stalleiken, P. Wenzel, T. Münzel, A. Daiber (Mainz, Karlsruhe) |
|
(P1746) |
Apoptosis resistance of pulmonary arterial smooth muscle cells in PH can be reversed by inhibition of PI3Kα |
| |
|
M. Vantler, E. M. Berghausen, A. Behringer, R. Savai, S. Savai Pullamsetti, R. Schermuly, S. Baldus, S. Rosenkranz (Köln, Bad Nauheim, Gießen) |